Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07807371) titled 'Timing of Subcutaneous Tranexamic Acid Injection in Mohs Micrographic Surgery' on Sept. 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Single (Participant).

Primary Sponsor: The Cooper Health System

Condition: Healthy

Intervention: Drug: Subcutaneous TXA injection before reconstruction

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: November 1, 2026

Target Sample Size: 500

To know more, visit https://clinicaltrials.gov/study/NCT07807371

Disclaimer: Curated by HT Syndication....